Status:
COMPLETED
Emergence of Fluoroquinolone Resistance in Commensal Flora
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
All Types of Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The emergence of resistance to fluoroquinolone (FQ) is a major problem worldwide. The commensal flora is the main reservoir for antibiotic resistance. Understanding the factors (environmental, patient...
Detailed Description
Population involved: Patients hospitalized (\>1day) in one of the two participating university hospitals and receiving a treatment by a fluoroquinolone (FQ) antibiotic. Number of centers : 2 (SAINT L...
Eligibility Criteria
Inclusion
- Hospitalisation \>24hours in one of the participating wards Treatment by a fluoroquinolone antibiotic.
Exclusion
- Pregnancy or breast feeding Patients refusal to participate
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
571 Patients enrolled
Trial Details
Trial ID
NCT01209247
Start Date
October 1 2010
End Date
December 1 2012
Last Update
April 19 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
De Lastours Victoire
Paris, France